Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells Laween UthmanMarius KuschmaNina C. Weber Original Article Open access 13 October 2020 Pages: 1083 - 1094
Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin Refaat A. EidMohammad Adnan KhalilAbdullah S. Shatoor Original Article 30 May 2020 Pages: 1095 - 1110
Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats Feng-Yen LinChun-Min ShihChien-Sung Tsai Original Article 04 July 2020 Pages: 1111 - 1127
Idebenone Protects against Atherosclerosis in Apolipoprotein E-Deficient Mice Via Activation of the SIRT3-SOD2-mtROS Pathway Wei JiangHongzhi GengChuanzhu Yan Original Article 17 June 2020 Pages: 1129 - 1145
Association of CYP2C19 Loss-of-Function Alleles with Major Adverse Cardiovascular Events of Clopidogrel in Stable Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention: Meta-analysis Mohitosh BiswasSumaiya Khatun Kali Original Article 01 February 2021 Pages: 1147 - 1159
Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Coronary Artery Disease Felix HoferNiema KazemAlexander Niessner Original Article 05 March 2021 Pages: 1161 - 1170
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational Registries Matteo BiancoAlessandro CareggioEnrico Cerrato Original Article 05 July 2021 Pages: 1171 - 1182
Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity? Maximilian TscharrePatricia P. WadowskiThomas Gremmel Original Article Open access 18 December 2020 Pages: 1183 - 1190
Is It Safe (and When) to Stop Oral Anticoagulation After Ablation for Atrial fibrillation? (Do We Have Enough Evidence to Solve the Dilemma?) José Luis MerinoJuan Tamargo Invited Editorial 07 September 2021 Pages: 1191 - 1204
Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review Zhi-Chun HuangChang-Qing LiJian-jun Sun Original Article 03 September 2020 Pages: 1205 - 1215
Network Meta-Analysis of Drug Therapies for Lowering Uric Acid and Mortality Risk in Patients with Heart Failure Satoru KodamaKazuya FujiharaHirohito Sone Original Article 23 October 2020 Pages: 1217 - 1225
Cardioprotective Potential of Exogenous Ubiquitin Suman DalalPaige L. ShookKrishna Singh Invited Review Article 10 September 2020 Pages: 1227 - 1232
Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment Daan C.H. van DorstNathalie P. de WagenaarA.H. Jan Danser Invited Review Article Open access 07 December 2020 Pages: 1233 - 1252
Sodium-Glucose Cotransporter-2 Inhibitors in Vascular Biology: Cellular and Molecular Mechanisms Lei XiaoXin NieNanping Wang Invited Review Article 17 July 2021 Pages: 1253 - 1267
Lipid-Lowering Biotechnological Drugs: from Monoclonal Antibodies to Antisense Therapies—a Clinical Perspective Xiaoming JiaJing LiuSalim S. Virani Original Article 30 September 2020 Pages: 1269 - 1279
Generation of a Novel In Vitro Model to Study Endothelial Dysfunction from Atherothrombotic Specimens Susan GalloglyTakeshi FujisawaOlga Tura-Ceide BSCR Member Submissions Open access 20 February 2021 Pages: 1281 - 1290
Restoring Perivascular Adipose Tissue Function in Obesity Using Exercise Sophie N SaxtonLauren K TomsAnthony M Heagerty BSCR Member Submissions Open access 09 March 2021 Pages: 1291 - 1304
